002923 Zhuhai Rundu Pharmaceutical
- 9.64
- +0.38+4.10%
About Zhuhai Rundu Pharmaceutical Company
The company is a modern technology-based pharmaceutical enterprise integrating drug research and development, production and sales. It is located in Jinwan District, Zhuhai City, Guangdong Province, and was founded in 1999. On January 5, 2018, the company was listed on the Shenzhen Stock Exchange. The company's main business is R&D, production and sales of chemical preparations, chemical raw materials, and pharmaceutical intermediates. The main products include rabeprazole sodium enteric capsules, irbesartan capsules, sartan raw materials and pharmaceutical intermediates. The product application range covers various drug fields such as peptic ulcers, high blood pressure, surgical local anesthesia, antipyretic analgesia, anti-infectious diseases, and diabetes. Corporate honors: National High-tech Enterprise; Guangdong Enterprise Technology Center; Guangdong Innovative Enterprise; National Torch Program Key High-tech Enterprise; Guangdong Engineering Technology Research Center; Guangdong Strategic Emerging Industry Cultivating Enterprise; National Postdoctoral Research Workstation; Guangdong Private Enterprise Innovation and Industrialization Demonstration Base; Passed the National Intellectual Property Management System certification. Some products have also received honorary titles such as the China Intellectual Property Excellence Award, Guangdong Famous High-tech Product, China Pharmaceutical's Leading Brand of the Year for High Quality Development, and Zhuhai Innovative Product.
Company Profile
Company Executives
- Name
- Position
- Salary
- xinmin chen
- Chairman, Directors, Chairman of the Strategy Committee
- 742.80K
- LIAO RAN
- Directors, Member of the Strategy Committee, Audit Committee Member
- --
- jie liu
- Directors, General Manager, Member of the Remuneration and Assessment Committee, Member of the Strategy Committee
- 693.50K
- chunyan you
- Directors, Deputy General Manager, Nomination Committee Members, Member of the Strategy Committee
- 672.70K
- wen tan
- Independent Directors, Member of the Strategy Committee, Chairman of the Nomination Committee
- --
- jianmu ye
- Independent Directors, Chairman of the Audit Committee, Member of the Remuneration and Assessment Committee
- 88.30K
- bo wang
- Independent Directors, Audit Committee Member, Chairman of the Remuneration and Assessment Committee, Nomination Committee Members
- 88.30K
- jun su
- Board Secretary
- 532.80K
- jieyun ye
- Securities Affairs Representative
- --
- zhijun hua
- Chairman of the Supervisory Board, Auditors
- 10.00K
- na li
- Auditors
- 234.40K
- shenhua shi
- Deputy General Manager, Chief Financial Officer
- 572.40K
- qiang cai
- Deputy General Manager
- 553.10K
- wei chen
- Deputy General Manager
- 532.70K
- gang lin
- Internal Audit Officer
- --
- jiawei guo
- Employee Supervisors
- 220.70K
Analysis
Price Target
No Data
No Data